I

106TH CONGRESS

1ST SESSION H. R. 961

To amend the Public Health Service Act to provide for programs regarding

ovarian cancer.

IN THE HOUSE OF REPRESENTATIVES

MARCH 3, 1999

Mrs. MINK of Hawaii introduced the following bill; which was referred to the

Committee on Commerce

A BILL

To amend the Public Health Service Act to provide for

programs regarding ovarian cancer.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘Ovarian Cancer

5 Research and Information Amendments of 1999’’.

6 SEC. 2. RESEARCH ON OVARIAN CANCER.

7 Section 417B(b)(2) of the Public Health Service Act

8 is amended—
2

•HR 961 IH

1 (1) by striking ‘‘CANCERS.—For the purpose

2 of’’ and all that follows through ‘‘417,’’ and insert3 ing the following: ‘‘CANCERS.—

4 ‘‘(A) For the purpose of carrying out sec5 tion 417(d),’’; and

6 (2) by adding at the end the following subpara7 graph:

8 ‘‘(B)(i) For the purpose of carrying out re9 search under section 417(d) on ovarian cancer,

10 there are authorized to be appropriated

11 $150,000,000 for fiscal year 2000, and such

12 sums as may be necessary for each of the fiscal

13 years 2001 and 2002. With respect to such pur14 pose, such authorizations of appropriations are

15 in addition to the authorizations of appropria16 tions established in subparagraph (A) and in

17 subsection (a).

18 ‘‘(ii) Of the amounts appropriated under

19 clause (i) for a fiscal year, the Director of the

20 Institute shall reserve 50 percent for research

21 described in such clause that does not involve

22 treatment or clinical trials, and 50 percent for

23 research described in such clause that does in24 volve treatment and clinical trials.
3

•HR 961 IH

1 ‘‘(iii) In expending the amounts appro2 priated under clause (i) for a fiscal year, the

3 Director of the Institute shall give priority to

4 the following activities regarding ovarian can5 cer:

6 ‘‘(I) Developing a test for the early

7 detection of the cancer.

8 ‘‘(II) Research to identify precursor

9 lesions and research to determine the man10 ner in which benign conditions progress to

11 malignant status.

12 ‘‘(III) Research to determine the rela13 tionship between the cancer and endo14 metriosis.

15 ‘‘(IV) Ensuring that, in clinical re16 search on the cancer that is conducted or

17 supported by the Institute, appropriate

18 counseling is provided to women before the

19 women participate as subjects in the re20 search, including (subject to changes in the

21 applicable facts) informing women that

22 there may be a genetic basis to such can23 cer.’’.
4

•HR 961 IH

1 SEC. 3. PUBLIC INFORMATION AND EDUCATION ON OVAR2 IAN CANCER.

3 Section 417(d)(4) of the Public Health Service Act

4 is amended by striking ‘‘section 413; and’’ and inserting

5 the following: ‘‘section 413, which programs shall include

6 programs on ovarian cancer that (subject to changes in

7 the applicable facts) provide information and education

8 regarding—

9 ‘‘(A) screening procedures for such cancer,

10 including the fact that there is not a procedure

11 that reliably provides for the early detection of

12 such cancer;

13 ‘‘(B) the fact that there may be a genetic

14 basis to such cancer;

15 ‘‘(C) factors indicating a substantial risk

16 of such cancer; and

17 ‘‘(D) the various treatments for such can18 cer and the extent to which the treatments are

19 effective; and’’.

20 SEC. 4. MEMBERSHIP OF NATIONAL CANCER ADVISORY

21 BOARD.

22 The membership of the National Cancer Advisory

23 Board under section 406(h)(2) of the Public Health Serv24 ice Act shall include one or more individuals who are at

25 high risk for developing ovarian cancer.
5

•HR 961 IH

1 SEC. 5. EFFECTIVE DATE.

2 This Act takes effect October 1, 1999, or upon the

3 date of the enactment of this Act, whichever occurs later.

Æ